Giuseppe Pantaleo Selected Research

NYVAC-C vaccine

10/2011

DNA/NYVAC vaccine regimen induces HIV-specific CD4 and CD8 T-cell responses in intestinal mucosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giuseppe Pantaleo Research Topics

Disease

39	Infections 02/2024 - 03/2002
15	HIV Infections (HIV Infection) 04/2022 - 03/2002
11	COVID-19 01/2023 - 01/2021
11	Neoplasms (Cancer) 01/2023 - 12/2008
8	Acquired Immunodeficiency Syndrome (AIDS) 01/2018 - 02/2003
7	Virus Diseases (Viral Diseases) 01/2022 - 04/2004
6	Disease Progression 01/2021 - 02/2003
5	Viremia 05/2017 - 01/2010
4	Persistent Infection 11/2019 - 01/2007
4	Human Influenza (Influenza) 10/2018 - 05/2005
3	Vaccinia 01/2023 - 01/2012
3	Inflammation (Inflammations) 01/2022 - 07/2017
3	Tuberculosis (Tuberculoses) 01/2019 - 05/2012
3	Progressive Multifocal Leukoencephalopathy 01/2014 - 03/2010
3	Multiple Sclerosis 04/2011 - 03/2010
2	Endotoxemia 02/2024 - 09/2014
2	Reinfection 01/2023 - 07/2014
2	Hemorrhage 03/2022 - 01/2020
2	Lymphoma (Lymphomas) 01/2022 - 11/2016
2	Hypersensitivity (Allergy) 11/2019 - 01/2019
2	Multiple Myeloma 05/2017 - 11/2015
2	Pain (Aches) 01/2017 - 10/2016
2	Yellow Fever 07/2014 - 12/2008
2	Smallpox (Variola) 10/2011 - 06/2007
2	Coinfection 10/2008 - 08/2002
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2024
1	Sepsis (Septicemia) 02/2024
1	Critical Illness (Critically Ill) 02/2024
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Hyperplasia 01/2022
1	Epstein-Barr Virus Infections 01/2022
1	Lymphadenopathy 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2021
1	Anuria 01/2021

Drug/Important Bio-Agent (IBA)

31	VaccinesIBA 07/2023 - 04/2004
11	CytokinesIBA 01/2023 - 08/2010
9	Antiviral Agents (Antivirals)IBA 09/2023 - 08/2002
9	AntigensIBA 11/2019 - 05/2006
8	AntibodiesIBA 07/2023 - 01/2018
7	Immunoglobulin G (IgG)IBA 07/2023 - 11/2020
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
6	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2009
6	AIDS VaccinesIBA 01/2017 - 09/2010
5	Biomarkers (Surrogate Marker)IBA 02/2024 - 05/2012
5	Neutralizing AntibodiesIBA 01/2023 - 07/2013
4	Monoclonal AntibodiesIBA 01/2023 - 01/2021
4	ChemokinesIBA 01/2021 - 03/2015
4	Interleukin-2 (IL2)IBA 06/2010 - 05/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 11/2015
2	AcidsIBA 10/2022 - 10/2015
2	mRNA VaccinesIBA 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 10/2019
2	env Gene ProductsIBA 01/2022 - 11/2019
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 08/2002
2	2019-nCoV Vaccine mRNA-1273IBA 01/2022 - 01/2022
2	A-Form DNA (A-DNA)IBA 01/2022 - 11/2019
2	BNT162 VaccineIBA 01/2022 - 01/2022
2	Complement System Proteins (Complement)IBA 01/2021 - 03/2002
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2013
2	Epoetin Alfa (Epogen)FDA Link 05/2017 - 09/2014
2	Biosimilar PharmaceuticalsIBA 05/2017 - 09/2014
2	Saline SolutionIBA 02/2017 - 01/2017
2	EpitopesIBA 01/2017 - 10/2007
2	EnzymesIBA 06/2016 - 09/2015
1	talimogene laherparepvecIBA 04/2024
1	EndotoxinsIBA 02/2024
1	Immune Checkpoint InhibitorsIBA 01/2023
1	MicronutrientsIBA 01/2023
1	ruxolitinibIBA 01/2023
1	Immunoglobulin A (IgA)IBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	DNA VaccinesIBA 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2023
1	CelluloseIBA 10/2022
1	PectinsIBA 10/2022
1	Biopolymers (Biopolymer)IBA 10/2022
1	SolventsIBA 10/2022
1	MidkineIBA 01/2022
1	Calcineurin InhibitorsIBA 01/2022
1	Abatacept (Orencia)FDA Link 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2021
1	AutoantibodiesIBA 01/2021
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021
1	eculizumab FDA Link 01/2021
1	AlbuminsIBA 01/2021

Therapy/Procedure

19	Therapeutics 04/2024 - 01/2010
4	Highly Active Antiretroviral Therapy (HAART) 07/2014 - 03/2002
3	Art Therapy 11/2019 - 02/2004
2	Drug Therapy (Chemotherapy) 11/2016 - 01/2016
2	Immunotherapy 01/2012 - 06/2010
2	Liver Transplantation 01/2010 - 10/2008
1	Heart Transplantation (Grafting, Heart) 04/2024
1	Critical Care (Surgical Intensive Care) 02/2024
1	Sinus Floor Augmentation 03/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022